Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
The Green Metals Royalty Company: Two Revenue Producing Royalties & More on the Way (click to learn more)
Trillion Achieves Record Revenues in Q1 at $8.3 million (click to learn more)
Argentina Lithium Announces Positive Results from Drill Campaign at Rincon West (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc.
INM
Healthcare
Biotechnology
Cannabis
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and...
development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(23)
•••
zardoz00
X
Post by
zardoz00
on May 15, 2023 2:47pm
INM Q3 report
https://mailchi.mp/d9827ae25b92/inmed-reports-second-quarter-fiscal-2023-financial-results-and-provides-business-update-13895526?e=5815d309bc
(23)
•••
zardoz00
X
Post by
zardoz00
on Mar 13, 2023 8:56am
INM publishes peer reviewed study
https://mailchi.mp/dc7a414475c6/inmed-announces-publication-of-peer-reviewed-study-showing-the-anti-inflammatory-potential-of-rare-cannabinoids-in-skin-conditions?e=5815d309bc
(62)
•••
kijiji
X
Post by
kijiji
on Feb 20, 2023 1:16pm
InMed 2nd Quarter Fiscal 2023 Results business update
VANCOUVER - InMed Pharmaceuticals Inc. ('InMed' or the 'Company') (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and
...more
(30)
•••
Stevemin
X
Comment by
Stevemin
on Dec 21, 2022 4:54pm
RE:Where are all of the Adams fanboys?
I haven't posted here in a while because theres no need. No one wanted to hear the truth. Yet I am replying to a message i sent back in early April. Everything i said was true (except Adams hasnt
...more
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Dec 02, 2022 2:03pm
BIDEN SIGNS CANNABIS BILL
https://www.marijuanamoment.net/biden-signs-marijuana-research-bill-a-historic-first-for-federal-cannabis-reform/
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Nov 16, 2022 9:50pm
Chuck Schumer - Research Act
The Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act that passed the House this year Itd help eliminate red tape hindering cannabis research for new treatments Now it goes to
...more
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2022 3:40pm
INM ..... All that Volume & Price Action for what ?
I'll tell ya....... Its a fair trade...... your paper money for their paper ; ) Look at the positive ...... their paper is "marketable" What a game ! Next support is ~ $3.60 ish
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 16, 2022 11:40am
INM ..... early a.m runner now in PB mode
Broke support at $4.22 Just might be done No position
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Oct 13, 2022 11:05pm
Radicle Science THCV study
Radicle study due out this month. https://www.prnewswire.com/news-releases/named-by-kpmg-as-one-of-americas-top-10-tech-innovators-radicle-science-bridges-proof-gap-for-health--wellness-industry
...more
(54)
•••
Bullknit101
X
Comment by
Bullknit101
on Oct 05, 2022 9:09pm
RE:Curaleaf Buys Tryke
Erratum - correction. Not Tryke, Trokie. https://investors.inmedpharma.com/news-releases/news-release-details/inmed-supply-rare-cannabinoids-radicle-sciences-radicle-energy/
(54)
•••
Bullknit101
X
Post by
Bullknit101
on Oct 05, 2022 9:06pm
Curaleaf Buys Tryke
The largest Cannabis company in the world with ~1.5B in annual revenue just bought Tryke. InMed is supplying Tryke with THCV for the Radicle Science study. Might be a light at the end of the
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 23, 2022 12:30pm
New Press Release - InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 19, 2022 6:00pm
New Press Release - InMed Pharmaceuticals to Report Full Year Fiscal 2022 Financial Results and Business Update on September 23, 2022
VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on Friday, September 23, 2022 for the fiscal year ended...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 13, 2022 5:13pm
New Press Release - InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced the closing of its previously announced private placement with two...
read article.
(26)
•••
BryceCanada
X
Post by
BryceCanada
on Sep 12, 2022 3:08pm
Excellent YT analysis on InMed!
https://youtu.be/YR3whoRE5lg
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
Exclusive Insights on the Precious Metals Industry and What to Expect in 2023 – Download free report
Q2 Metals Initiates Phase Two of Exploration Work at Its Mia Lithium Property in James Bay, Quebec
INEO Announces Fiscal Third Quarter Financial Results Reporting 19% Increase in Revenue
Noble Mineral Exploration to Acquire a Mining Claim in Newfoundland Covering Approximately 175 Hectares
Green Metals Royalty Company: "The Perfect Junior Mining Investment?" - Read More Here
Milestone Agreement for Developing Radiology Drugs Announced